Skip to Content
MIT News magazine

Pitcher Perseveres

Injured alum hopes for a major-league comeback.

In 2004, Jason Szuminski ‘00 made history as the first MIT alumnus to play major-league baseball, appearing in seven games as a relief pitcher for the San Diego Padres. But after Szuminski returned to the Chicago Cubs, the team that had drafted him shortly before graduation, he got sent back to the minors and developed tendinitis and then injured his shoulder. He had surgery in June 2005 to repair a torn labrum.

Jason Szuminski ‘00

“It’s frustrating watching all the action of spring training when you can’t be out on the field playing,” says Szuminski, who rehabbed after surgery at the Cubs’ spring training facility in Arizona. Then, on March 22, the Cubs released him.

“This was my last year on my contract with the Cubs, and I had a pretty good feeling they would release me later in the summer,” he says. “They did surprise me by jumping the gun, but it really doesn’t change a whole lot.”

“I can’t play for anybody until I finish my rehab and get my arm back to pitching, so getting well is still the number one priority,” says Szuminski, who is now rehabbing at a private facility that caters to professional athletes. His agent, Andy Lipman, agrees. “We’ve been talking to some teams,” he says, “but he’s got to get healthy.”

Whether or not he makes it back to the majors, Szuminski still goes down in the record books as the first MIT graduate to appear on a major-league baseball card. (Art Merewether, SM ‘25, and Skip Lockwood, SM ‘83, both attended MIT after their professional baseball careers.) “It’s pretty neat to have your own card,” says Szuminski. “You can actually buy them on eBay.”

Keep Reading

Most Popular

Rendering of Waterfront Toronto project
Rendering of Waterfront Toronto project

Toronto wants to kill the smart city forever

The city wants to get right what Sidewalk Labs got so wrong.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.